Asia Pacific Ai-based Clinical Trials Solution Provider Market Size & Outlook
Asia Pacific ai-based clinical trials solution provider market, 2018-2030 (US$M)
Related Markets
Asia Pacific ai-based clinical trials solution provider market highlights
- The Asia Pacific ai-based clinical trials solution provider market generated a revenue of USD 197.4 million in 2021.
- The market is expected to grow at a CAGR of 28.9% from 2022 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic applications in 2021.
- CVD is the most lucrative therapeutic applications segment registering the fastest growth during the forecast period.
- Country-wise, Australia is expected to register the highest CAGR from 2022 to 2030.
Asia Pacific data book summary
| Market revenue in 2021 | USD 197.4 million |
| Market revenue in 2030 | USD 1,944.1 million |
| Growth rate | 28.9% (CAGR from 2021 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | CVD |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
| Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 15.0% of the global ai-based clinical trials solution provider market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,944.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI-based Clinical Trials Solution Provider Market Scope
AI-based Clinical Trials Solution Provider Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific ai-based clinical trials solution provider market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.2% in 2021. Horizon Databook has segmented the Asia Pacific ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is the fastest-growing market, as many developed nations are investing in this region. It is also developing in terms of healthcare infrastructure, technology, clinical research, and adoption of advanced solutions.
Moreover, recruitment for clinical trials is increasing in Asia as compared to North America and Europe. This is due to presence of large patient pool & low trial cost.
Furthermore, as per Novotech’s CEO, Asia Pacific is now recognized by clinical phase biotechnology firms for accelerated patient enrollment, especially in infectious diseases, oncology, metabolic conditions, immune-oncology, and rare diseases as well as low cost of clinical research combined with experienced investigators & research teams.
Reasons to subscribe to Asia Pacific ai-based clinical trials solution provider market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific ai-based clinical trials solution provider market databook
-
Our clientele includes a mix of ai-based clinical trials solution provider market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific ai-based clinical trials solution provider market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific artificial intelligence based clinical trials solution provider market size, by country, 2018-2030 (US$M)
Asia Pacific AI-based Clinical Trials Solution Provider Market Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
